CLL Variant
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL (NCT07014917) | Zulfa Omer | 2025-12-05 |
Track CLL Variant automatically
Every clearance here is in the API, with alerts when new ones post.